HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,465,350 | +2.8% | 16,358 | -2.3% | 0.06% | +9.3% |
| Q2 2023 | $1,425,329 | +2.4% | 16,741 | -0.5% | 0.05% | -1.8% |
| Q1 2023 | $1,392,269 | -9.8% | 16,825 | -2.1% | 0.06% | -11.3% |
| Q4 2022 | $1,544,049 | +21.5% | 17,179 | 0.0% | 0.06% | +8.8% |
| Q3 2022 | $1,271,000 | +12.7% | 17,179 | -0.8% | 0.06% | +16.3% |
| Q2 2022 | $1,128,000 | +2.2% | 17,309 | -0.8% | 0.05% | +22.5% |
| Q1 2022 | $1,104,000 | +19.2% | 17,456 | 0.0% | 0.04% | +29.0% |
| Q4 2021 | $926,000 | -24.8% | 17,456 | 0.0% | 0.03% | -31.1% |
| Q3 2021 | $1,232,000 | +2.8% | 17,456 | -3.0% | 0.04% | +4.7% |
| Q2 2021 | $1,199,000 | -23.0% | 17,989 | +28.2% | 0.04% | -27.1% |
| Q1 2021 | $1,558,000 | -6.5% | 14,033 | 0.0% | 0.06% | -22.4% |
| Q4 2020 | $1,666,000 | +33.1% | 14,033 | -2.2% | 0.08% | +33.3% |
| Q3 2020 | $1,252,000 | -4.1% | 14,353 | -1.5% | 0.06% | -8.1% |
| Q2 2020 | $1,306,000 | -29.5% | 14,577 | -21.6% | 0.06% | -41.0% |
| Q1 2020 | $1,853,000 | -13.7% | 18,590 | -0.5% | 0.10% | +10.5% |
| Q4 2019 | $2,147,000 | -8.8% | 18,689 | +0.1% | 0.10% | -12.0% |
| Q3 2019 | $2,355,000 | +1.7% | 18,667 | -3.0% | 0.11% | +2.9% |
| Q2 2019 | $2,316,000 | +37.6% | 19,242 | 0.0% | 0.10% | +34.6% |
| Q1 2019 | $1,683,000 | -14.1% | 19,242 | -1.8% | 0.08% | -27.1% |
| Q4 2018 | $1,960,000 | -12.1% | 19,591 | +0.7% | 0.11% | +3.9% |
| Q3 2018 | $2,229,000 | +25.4% | 19,451 | -1.9% | 0.10% | +19.8% |
| Q2 2018 | $1,778,000 | +433.9% | 19,821 | +335.8% | 0.09% | +437.5% |
| Q1 2018 | $333,000 | +29.6% | 4,548 | +2.9% | 0.02% | +33.3% |
| Q4 2017 | $257,000 | +35.3% | 4,419 | 0.0% | 0.01% | +33.3% |
| Q3 2017 | $190,000 | +8.6% | 4,419 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $175,000 | -2.2% | 4,419 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $179,000 | -14.8% | 4,419 | -5.3% | 0.01% | -35.7% |
| Q1 2015 | $210,000 | – | 4,665 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |